A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients

Breast Cancer Research and Treatment

Volumn 146, Issue 1, 2014, Pages 63-69

  Seong, Moon Woo ^a   Kim, Kyu Hyung ^b   Chung, Il Yong ^c   Kang, Eunyoung ^b   Lee, Jong Won ^d   Park, Sue K ^e,f   Lee, Min Hyuk ^g   Lee, Jeong Eon ^h   Noh, Dong Young ^e   Son, Byung Ho ^d   Park, Hai Lin ⁱ   Cho, Sung Im ^a   Park, Sung Sup ^a   Kim, Sung Won ^b   Kwak, Beom Seok ^j   Park, Byeong Woo ^j   Moon, Byung In ^j   Yom, Cha Kyong ^j   Park, Chan Heun ^j   Yoon, Chan Seok ^j   Lee, Chang Hyun ^j   Yoon, Dae Sung ^j   Choi, Doo Ho ^j   Chang, Eundeok ^j   Kim, Eun Kyu ^j   Lee, Hae Kyung ^j   Lee, Hyde ^j   Moon, Hyeong Gon ^j   Kim, Hyun Ah ^j   Lee, Il Kyun ^j   Lee, Jihyoun ^j   Yu, Jong Han ^j   Jeong, Joon ^j   Yoon, Jung Han ^j   Yang, Jung Hyun ^j   Kwak, Keumhee ^j   Hwang, Ki Tae ^j   Kim, Ku Sang ^j   Kim, Lee Su ^j   Hur, Min Hee ^j   Park, Min Ho ^j   Chang, Myung Chul ^j   Paik, Nam Sun ^j   Han, Sang Ah ^j   Jung, Sang Seol ^j   Woo, Sang Uk ^j   Oh, Se Jeong ^j   Han, Sehwan ^j   Kim, Sei Joong ^j   Ahn, Sei Hyun ^j   Nam, Seok Jin ^j   Ko, Seung Sang ^j   Jung, Sung Hoo ^j   Kang, Sung Soo ^j   Kim, Sung Yong ^j   Kim, Tae Hyun ^j   Won, Tae Wan ^j   Kang, Tae Woo ^j   Han, Wonshik ^j   Noh, Woo Chul ^j   Park, Yong Lai ^j   Jung, Yongsik ^j   Suh, Young Jin ^j   Bae, Young Tae ^j   Cho, Young Up ^j   Hong, Young Ik ^j   Jung, Yoon Joo ^j   Choi, Su Yun ^j   Yoo, Young Bum ^j   Lee, Soo Jung ^j   more..

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c National Medical Center   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f Seoul National University   (South Korea)

^g Soonchunhyang University College of Medicine   (South Korea)

^h Samsung Medical Center   (South Korea)

ⁱ CHA University   (South Korea)

^j Department of Surgery Seoul National University College of Medicine Seoul National University ^*

more..

Author keywords

BRCA1; BRCA2; Breast cancer; Hereditary cancer; TNBC; Triple negative breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GENOMIC DNA; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KOREA; LARGE GENOMIC REARRANGEMENT; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ONSET AGE; OVARY CANCER; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE; BREAST NEOPLASMS; CLINICAL TRIAL; GENETICS; MIDDLE AGED; MULTICENTER STUDY; MUTATION; OVARY TUMOR; PATHOLOGY; PROGNOSIS; RISK FACTOR; SOUTH KOREA; TRIPLE NEGATIVE BREAST NEOPLASMS; YOUNG ADULT;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREVALENCE; PROGNOSIS; REPUBLIC OF KOREA; RISK FACTORS; TRIPLE NEGATIVE BREAST NEOPLASMS; YOUNG ADULT;

EID: 84903697051     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3006-7     Document Type: Article

References (21)

1. Rummel S, Varner E, Shriver CD, Ellsworth RE (2013) Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. Breast Cancer Res Treat 137(1):119-125
2. Rakha EA, Ellis IO (2009) Triple-negative/basal-like breast cancer: review. Pathology 41(1):40-47
3. Andres R, Pajares I, Balmana J, Llort G, Ramon YCT, Chirivella I, Aguirre E, Robles L, Lastra E, Perez-Segura P et al (2014) Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC). Clin Transl Oncol 16(3):280-284
4. Tun NM, Villani G, Ong K, Yoe L, Bo ZM (2014) Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis. Clin Genet 85(1):43-48
5. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295(12):1379-1388
6. Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25(5):415-422
7. Seong MW, Cho SI, Noh DY, Han W, Kim SW, Park CM, Park HW, Kim SY, Kim JY, Park SS (2009) Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population. Fam Cancer 8(4):505-508
8. Kim H, Cho DY, Choi DH, Choi SY, Shin I, Park W, Huh SJ, Han SH, Lee MH, Ahn SH et al (2012) Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer. Breast Cancer Res Treat 134(3):1315-1326
9. Seong MW, Cho SI, Noh DY, Han WS, Kim SW, Park CM, Park HY, Kim SY, Kim JY, Park SS (2009) Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients and evidence of a founder mutation. Clin Genet 76(2):152-160
10. Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE (2008) Molecular Subcommittee of the ALQAC: aCMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med 10(4):294-300 (Pubitemid 351544132)
11. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118-145 (Pubitemid 350003059)
12. Peshkin BN, Alabek ML, Isaacs C (2010) BRCA1/2 mutations and triple negative breast cancers. Breast Dis 32(1-2):25-33
13. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI (2011) Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Res Treat 126(3):671-678
14. Carey L, Winer E, Viale G, Cameron D, Gianni L (2010) Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol 7(12):683-692
15. Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70(17):2247-2258
16. Fostira F, Tsitlaidou M, Papadimitriou C, Pertesi M, Timotheadou E, Stavropoulou AV, Glentis S, Bournakis E, Bobos M, Pectasides D et al (2012) Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a hellenic cooperative oncology group study. Breast Cancer Res Treat 134(1):353-362
17. Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, Lanchbury JS, Stemke-Hale K, Hennessy BT, Arun BK et al (2011) Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res 17(5):1082-1089
18. Robertson L, Hanson H, Seal S, Warren-Perry M, Hughes D, Howell I, Turnbull C, Houlston R, Shanley S, Butler S et al (2012) BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer 106(6):1234-1238
19. Phuah SY, Looi LM, Hassan N, Rhodes A, Dean S, Taib NA, Yip CH, Teo SH (2012) Triple-negative breast cancer and PTEN (phosphatase and tensin homologue)loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer. Breast Cancer Res 14(6):R142
20. NCCN (2014) Clinical practice guidelines in oncology: genetic/familial high-risk assessment: breast and ovarian, vol 2014. National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician-gls/pdf/genetics- screening.pdf. Accessed 20 April 2014
21. NICE (2013) Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer, vol 2013. National Institute for Health and Care Excellence (NICE), 2013. http://www.nice.org.uk/nicemedia/ live/14188/64202/64202.pdf. Accessed 20 April 2014